5–7 Oct 2026
Harnack-Haus
Europe/Berlin timezone

Poster #66: Tin: A Minimalist Abortive PD-(D/E)XK Nuclease Fusing Sensor and Effector Functions for Anti-Phage Defense

5 Oct 2026, 21:15
1m
Meitner-Saal I + II (Harnack Haus)

Meitner-Saal I + II

Harnack Haus

Poster only Poster-Session

Speaker

Anton Derzhaev (Center for Bio- and Medical Technologies, Moscow, Russia)

Description

Bacterial abortive infection (Abi) systems typically require multi-component complexes to detect phages and execute cell death. We characterize Tin, a 253-amino-acid protein encoded by prophage P2, as one of the smallest known Abi proteins that mediate phage sensing and abortive response. We demonstrate that Tin protects against T4-like phages by directly recognizing the phage SSB protein gp32. Structural studies reveal that gp32 binds a dimeric core of Tin, stabilizing an activated conformation of the PD-(D/E)XK catalytic motif. Notably, Tin sensory loop integrates into and completes a nuclease domain after gp32 binding - a unique mechanism enabling sensor–effector fusion in such a compact protein. Upon activation, Tin non-discriminately degrades host and phage DNA, and demonstrates an activity against glucosyl-hydroxymethylcytosine-modified T4 genome, challenging the paradigm that such modifications universally block nucleases. Bioinformatic analysis links Tin to type I restriction-modification systems and NucC, underscoring its place among defense systems. This work explains how a regulation of the abortive nuclease can emerge via insertion of a short sensory loop interacting with the phage trigger.

Authors

Anton Derzhaev (Center for Bio- and Medical Technologies, Moscow, Russia) Artem Isaev (Center for Bio- and Medical Technologies, Moscow, Russia) Chunyi Hu (National University of Singapore, Singapore)

Co-authors

Konstantin Severinov (- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia) Kristina Potekhina (Center for Bio- and Medical Technologies, Moscow, Russia) Natalia Morozova (Center for Bio- and Medical Technologies, Moscow, Russia) Vadim Molodtsov (Research Institute of Molecular and Cellular Medicine, RUDN University, Moscow, Russia)

Presentation materials

There are no materials yet.